CTEV (Claritev Corporation) Stock Financials & Earnings | Market Cap Arena

CTEV (Claritev Corporation) Stock Financials & Earnings | Market Cap Arena

CTEVClaritev Corporation

Mkt Cap$276M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NYSE

Revenue (TTM)$965M

Net Income (TTM)-$284M

EPS (TTM)-$17.30

Free Cash Flow (TTM)-$12M

Gross Margin27.6%

Op. Margin4.7%

Net Margin-29.4%

FCF Margin-1.3%

P/S Ratio (TTM)0.3x

P/E Ratio (TTM)—

YoY Rev Growth+3.7%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$237M	$182M	$47M
Q2 23	$238M	$179M	$35M
Q3 23	$243M	$182M	$40M
Q4 23	$244M	$183M	$41M
Q1 24	$235M	$174M	-$486M
Q2 24	$233M	$172M	-$524M
Q3 24	$230M	$170M	-$338M
Q4 24	$232M	$175M	-$41M
Q1 25	$231M	$171M	$10M
Q2 25	$242M	$181M	$17M
Q3 25	$246M	$184M	$10M
Q4 25	$247M	-$269M	$9M

Valuation

Quarter	P/S	P/E
Q1 23	0.3x	—
Q2 23	0.3x	—
Q3 23	0.3x	—
Q4 23	0.3x	—
Q1 24	0.3x	—
Q2 24	0.3x	—
Q3 24	0.3x	—
Q4 24	0.3x	—
Q1 25	0.3x	—
Q2 25	0.3x	—
Q3 25	0.3x	—
Q4 25	0.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$64M	$41M
Q2 23	$8M	-$24M
Q3 23	$72M	$50M
Q4 23	$28M	-$4M
Q1 24	$50M	$19M
Q2 24	$18M	-$7M
Q3 24	$73M	$41M
Q4 24	-$34M	-$64M
Q1 25	-$30M	-$69M
Q2 25	$61M	$37M
Q3 25	$20M	-$16M
Q4 25	$66M	$36M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$23M
Q2 23	$32M
Q3 23	$22M
Q4 23	$31M
Q1 24	$31M
Q2 24	$25M
Q3 24	$32M
Q4 24	$30M
Q1 25	$39M
Q2 25	$25M
Q3 25	$36M
Q4 25	$30M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-20.6%	+4.5%
Q2 23	-18.0%	+5.7%
Q3 23	-3.1%	-5.0%
Q4 23	+1.3%	-76.2%
Q1 24	-0.9%	+280.1%
Q2 24	-1.9%	+272.6%
Q3 24	-5.1%	+179.8%
Q4 24	-4.9%	+34.5%
Q1 25	-1.4%	-69.3%
Q2 25	+3.5%	-70.3%
Q3 25	+6.7%	-58.5%
Q4 25	+6.2%	-13.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	1.6%
Q2 23	$5M	2.0%
Q3 23	$5M	2.0%
Q4 23	$5M	1.9%
Q1 24	$6M	2.4%
Q2 24	$7M	3.1%
Q3 24	$7M	3.0%
Q4 24	$0	0.0%
Q1 25	$7M	2.9%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$8M	3.2%

OpEx Breakdown

Quarter	G&A
Q1 23	$30M
Q2 23	$33M
Q3 23	$37M
Q4 23	$36M
Q1 24	$35M
Q2 24	$35M
Q3 24	$38M
Q4 24	$53M
Q1 25	$51M
Q2 25	$53M
Q3 25	$48M
Q4 25	$70M

Revenue Segments

Quarter	Analytic-Based Services	Network Services	Payment and Revenue Integrity Services
Q1 25	$153M	$47M	$31M
Q2 25	$157M	$54M	$30M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$266M	$0	$266M
Q2 23	$90M	$0	$90M
Q3 23	$101M	$0	$101M
Q4 23	$72M	$0	$72M
Q1 24	$59M	$0	$59M
Q2 24	$49M	$0	$49M
Q3 24	$87M	$0	$87M
Q4 24	$17M	$0	$17M
Q1 25	$23M	$0	$23M
Q2 25	$56M	$0	$56M
Q3 25	$51M	$0	$51M
Q4 25	$17M	$0	$17M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	16M	+0.3%
Q2 23	16M	+0.4%
Q3 23	16M	+0.5%
Q4 23	16M	-0.2%
Q1 24	16M	+0.2%
Q2 24	16M	-0.3%
Q3 24	16M	+0.2%
Q4 24	16M	+0.0%
Q1 25	16M	+0.8%
Q2 25	16M	+1.1%
Q3 25	16M	+0.2%
Q4 25	16M	-0.3%